Component alignment cannot fully explain total knee arthroplasty [TKA] performance with regards to patient reported outcomes and pain. Patient specific variations in musculoskeletal anatomy are one explanation for this. Computational simulations allow for the impact of component alignment and variable patient specific musculoskeletal anatomy on dynamics to be studied across populations. This study aims to determine if simulated dynamics correlate with Patient Reported Outcomes.

Landmarking of key anatomical points and 3D registration of implants was performed on 96 segmented post-operative CT scans of TKAs. A cadaver rig validated platform for generating patient specific rigid body musculoskeletal models was used to assess the resultant motions. Resultant dynamics were segmented and tested for differentiation with and correlation to a 6 month postoperative Knee injury and Osteoarthritis Outcome Score (KOOS).

Significant negative correlations were found between the postoperative KOOS symptoms score and the rollback occurring in midflexion (p<0.001), quadriceps force in mid flexion (p=0.025) and patella tilt throughout flexion (p=0.009, p=0.005, p=0.010 at 10°, 45° and 90° of flexion). A significant positive correlation was found between lateral shift of the patella through flexion and the symptoms score. (p=0.012) Combining a varus/valgus angular change from extension to full flexion between 0° and 4° (long leg axis) and measured rollback of no more than 6mm without roll forward forms a ‘kinematic safe zone’ of outcomes in which the postoperative KOOS score is 11.5 points higher (p=0.013).

The study showed statistically significant correlations between kinematic factors in a simulation of postoperative TKR and post-operative KOOS scores. The presence of a ‘kinematic safe zone’ in the data suggests a patient specific optimisation target for any given individual patient and the opportunity to preoperatively determine a patient specific alignment target.

Congenital pseudarthrosis of the tibia is an uncommon manifestation of neurofibromatosis type 1 (NF1), but one that remains difficult to treat due to anabolic deficiency and catabolic excess. Bone grafting and more recently recombinant human bone morphogenetic proteins (rhBMPs) have been identified as pro-anabolic stimuli with the potential to improve the outcome after surgery. As an additional pharmaceutical intervention, we describe the combined use of rhBMP-2 and the bisphosphonate zoledronic acid in a mouse model of NF1-deficient fracture repair.

Fractures were generated in the distal tibiae of neurofibromatosis type 1-deficient (Nf1^+/−) mice and control mice. Fractures were open and featured periosteal stripping. All mice received 10 μg rhBMP-2 delivered in a carboxymethylcellulose carrier around the fracture as an anabolic stimulus. Bisphosphonate-treated mice also received five doses of 0.02 mg/kg zoledronic acid given by intraperitoneal injection.

When only rhBMP but no zoledronic acid was used to promote repair, 75% of fractures in Nf1^+/− mice remained ununited at three weeks compared with 7% of controls (p < 0.001). Systemic post-operative administration of zoledronic acid halved the rate of ununited fractures to 37.5% (p < 0.07).

These data support the concept that preventing bone loss in combination with anabolic stimulation may improve the outcome following surgical treatment for children with congenital pseudarthoris of the tibia and NF1.